Showing results (221-230 of 233) with videos related to
Sort By:
Pageof 24
British Journal of Haematology|March 13, 2016
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402Michael E Williams, Fangxin Hong, Randy D Gascoyne, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2019
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple MyelomaSagar Lonial, Susanna Jacobus, Rafael Fonseca, et al.JAMA Network Open|March 27, 2024
Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple MyelomaJohn Devin Peipert, Fengmin Zhao, Ju-Whei Lee, et al.The New England Journal of Medicine|July 15, 2026
Continuous or Fixed-Duration Maintenance Therapy in Multiple MyelomaShaji Kumar, Susanna Jacobus, Adam Cohen, et al.The Lancet. Oncology|September 1, 2020
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trialShaji K Kumar, Susanna J Jacobus, Adam D Cohen, et al.Journal of the National Cancer Institute|January 7, 2026
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102)Marie Wood, Paul F Pinsky, Paul Novotny, et al.Clinical Immunology (Orlando, Fla.)|March 5, 2025
Autoantibody development is associated with clinical severity of COVID-19: A cohort studyMarie Brinkmann, Ludwig Traby, Manuel Kussmann, et al.Cancer|August 28, 2024
Feasibility of structuring electronic health record data to facilitate real-world data research: ICAREdata methods applied to multicenter cancer clinical trialsSuzanne George, Nancy Campbell, Shauna L Hillman, et al.Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.International Journal of Cancer|March 19, 2021
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinomaLionel A Kankeu Fonkoua, Sakti Chakrabarti, Mohamad B Sonbol, et al.Pageof 24